REQUEST A DEMO
Total
USD $0.00
Search more companies

BRDK Pharma Zrt. (Hungary)

Main Activities: Pharmacies and Drug Stores
Full name: BRDK Pharma Zrt. Profile Updated: August 16, 2023
Buy our report for this company USD 29.95 Most recent financial data: 2022 Available in: English & Hungarian Download a sample report

BRDK Pharma Zrt. is an enterprise located in Hungary, with the main office in Budapest. It operates in the Pharmacies and Drug Stores sector. The enterprise was incorporated on August 17, 2020. It currently has a total number of 8 (2023) employees. From the latest financial highlights, BRDK Pharma Zrt. reported a net sales revenue increase of 72.48% in 2022. There was a total growth of 235.63% in BRDK Pharma Zrt.’s total assets over the same period. The net profit margin of BRDK Pharma Zrt. increased by 5.11% in 2022.

Headquarters
Fehervari ut 200.
Budapest; Budapest; Postal Code: 1116

Contact Details: Purchase the BRDK Pharma Zrt. report to view the information.

Basic Information
Total Employees:
Purchase the BRDK Pharma Zrt. report to view the information.
Outstanding Shares:
Purchase the BRDK Pharma Zrt. report to view the information.
Registered Capital:
Purchase the BRDK Pharma Zrt. report to view the information.
Incorporation Date:
August 17, 2020
Key Executives
Purchase this report to view the information.
Chief Executive Officer
Ownership Details
Purchase this report to view the information.
49.8%
Purchase this report to view the information.
25.1%
Purchase this report to view the information.
25.1%
Company Performance
Financial values in the chart are available after BRDK Pharma Zrt. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency HUF. Absolute financial data is included in the purchased report.
Net sales revenue
72.48%
Total operating revenue
72.5%
Operating profit (EBIT)
308.45%
EBITDA
233.17%
Net Profit (Loss) for the Period
408.14%
Total assets
235.63%
Total equity
466.35%
Operating Profit Margin (ROS)
4.91%
Net Profit Margin
5.11%
Return on Equity (ROE)
-9.44%
Quick Ratio
0.49%
Cash Ratio
0.59%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?